Thromboinflammation and the hypercoagulability of COVID-19. Connors, J. M. & Levy, J. H. Journal of Thrombosis and Haemostasis.
Thromboinflammation and the hypercoagulability of COVID-19 [link]Paper  doi  abstract   bibtex   
The pathogenic coronavirus has been wreaking havoc worldwide since January. Infection with SARS-CoV-2 is problematic as no one has prior immunity, and no specific antiviral treatments are available. While many people with COVID-19 develop mild to moderate symptoms, some develop profound seemingly unchecked inflammatory responses leading to acute lung injury and hypoxemic respiratory failure, the most common cause for death.
@article{connors_thromboinflammation_nodate,
	title = {Thromboinflammation and the hypercoagulability of {COVID}-19},
	volume = {n/a},
	issn = {1538-7836},
	url = {https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14849},
	doi = {10.1111/jth.14849},
	abstract = {<b>The pathogenic coronavirus</b> has been wreaking havoc worldwide since January. Infection with SARS-CoV-2 is problematic as no one has prior immunity, and no specific antiviral treatments are available. While many people with COVID-19 develop mild to moderate symptoms, some develop profound seemingly unchecked inflammatory responses leading to acute lung injury and hypoxemic respiratory failure, the most common cause for death.},
	language = {en},
	number = {n/a},
	urldate = {2020-04-24},
	journal = {Journal of Thrombosis and Haemostasis},
	author = {Connors, Jean M. and Levy, Jerrold H.},
	file = {Snapshot:C\:\\Users\\mdwan\\Zotero\\storage\\DKSEST4E\\Connors and Levy - Thromboinflammation and the hypercoagulability of .html:text/html}
}

Downloads: 0